Download PDF
Thromb Haemost 2011; 105(04): 605-609
DOI: 10.1160/TH10-09-0626
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Association between γ′ fibrinogen levels and inflammation

Kristine S. Alexander
1   Department of Molecular and Medical Genetics, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA
,
Theresa E. Madden
2   Dr. Theresa E. Madden & Associates, PLLC, Olympia, Washington, USA
,
David H. Farrell
3   Division of Cardiovascular Medicine, Department of Medicine, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA
› Author Affiliations Financial support: This study was supported by the National Heart, Lung, and Blood Institute (R21HL097298 to D.H.F.) and by the Oregon Clinical and Translational Research Institute TL1 grant (1TL1RR024159 to K.S.A.) from the National Center for Research Resources, a component of the National Institutes of Health, and the NIH Roadmap for Medical Research.
Further Information

Publication History

Received: 29 September 2010

Accepted after major revision: 11 December 2010

Publication Date:
28 November 2017 (online)

Also available at
    Permissions and Reprints

Summary

The γ’ fibrinogen isoform produces clots that are stiffer and more resistant to breakdown than the more common fibrinogen isoform, γA. Increased levels of γ’ fibrinogen are associated with several forms of cardiovascular disease. The purpose of this cross-sectional study was to investigate the relationship between γ’ fibrinogen, an emerging risk factor for cardiovascular disease, and inflammatory markers in subjects with a chronic inflammatory state. The 284 subjects for this study came from the Periodontitis And Vascular Events (PAVE) study, and γ’ fibrinogen and total fibrinogen in plasma were measured by ELISA. Information on patient demographics and health status, as well as levels of C-reactive protein (CRP), an inflammatory marker, have previously been collected for this study. The mean (SE) γ’ fibrinogen level in the subjects was 0.622 (0.017) mg/ml. Levels of γ’ fibrinogen were correlated with CRP (p = 0.006), with a one unit increase in CRP associated with a 1.9% increase in γ’ fibrinogen, after adjustment for potential confounders. Total fibrinogen was not correlated with γ’ fibrinogen in these subjects. The number of dental sites with evidence of tissue inflammation was also significantly associated with γ’ fibrinogen levels. These results provide an important step in the evolution of γ’ fibrinogen not only as a general risk factor for cardiovascular disease, but as a potentially useful biomarker for assessing a patient’s inflammatory state and associated cardiovascular disease risk.

Keywords

Cardiovascular disease - γ’ fibrinogen - inflammation - periodontitis - risk factor
 

  • References

  • 1 Chung DW, Davie EW. γ and γ’ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232-4236.
    CrossrefPubMedGoogle Scholar
  • 2 Fornace Jr AJ, Cummings DE, Comeau CM. et al. Structure of the human γ-fibrinogen gene. Alternate mRNA splicing near the 3’ end of the gene produces γA and γB forms of γ-fibrinogen. J Biol Chem 1984; 259: 12826-12830.
    PubMedGoogle Scholar
  • 3 Lovely RS, Falls LA, Al-Mondhiry HA. et al. Association of γA/γ’ fibrinogen levels and coronary artery disease. Thromb Haemost 2002; 88: 26-31.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Mannila MN, Lovely RS, Kazmierczak SC. et al. Elevated plasma fibrinogen γ’ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. J Thromb Haemost 2007; 5: 766-773.
    CrossrefPubMedGoogle Scholar
  • 5 Lovely RS, Kazmierczak SC, Massaro JM. et al. γ’ fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease. Clin Chem 2010; 56: 781-788.
    CrossrefPubMedGoogle Scholar
  • 6 Meh DA, Siebenlist KR, Mosesson MW. Identification and characterization of the thrombin binding sites on fibrin. J Biol Chem 1996; 271: 23121-5.
    CrossrefPubMedGoogle Scholar
  • 7 Lovely RS, Moaddel M, Farrell DH. Fibrinogen γ’ chain binds thrombin exosite II. J Thromb Haemost 2003; 1: 124-131.
    CrossrefPubMedGoogle Scholar
  • 8 Pospisil CH, Stafford AR, Fredenburgh JC. et al. Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin. J Biol Chem 2003; 278: 21584-21591.
    CrossrefPubMedGoogle Scholar
  • 9 Sabo TM, Farrell DH, Maurer MC. Conformational analysis of γ’ peptide (410–427) interactions with thrombin anion binding exosite II. Biochemistry 2006; 45: 7434-7445.
    CrossrefPubMedGoogle Scholar
  • 10 Pineda AO, Chen ZW, Marino F. et al. Crystal structure of thrombin in complex with fibrinogen γ’ peptide. Biophysical Chem 2007; 125: 556-559.
    CrossrefPubMedGoogle Scholar
  • 11 Falls LA, Farrell DH. Resistance of γA/γ’ fibrin clots to fibrinolysis. J Biol Chem 1997; 272: 14251-14256.
    CrossrefPubMedGoogle Scholar
  • 12 Collet JP, Nagaswami C, Farrell DH. et al. Influence of γ’ fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arterioscler Thromb Vasc Biol 2004; 24: 382-386.
    CrossrefPubMedGoogle Scholar
  • 13 Cooper AV, Standeven KF, Ariëns RA. Fibrinogen γ-chain splice variant γ’ alters fibrin formation and structure. Blood 2003; 102: 535-540.
    CrossrefPubMedGoogle Scholar
  • 14 Gersh KC, Nagaswami C, Weisel JW. et al. The presence of γ’ chain impairs fibrin polymerization. Thromb Res 2009; 124: 356-363.
    CrossrefPubMedGoogle Scholar
  • 15 de Willige SU, Standeven KF, Philippou H. et al. The pleiotropic role of the fibrinogen γ’ chain in hemostasis. Blood 2009; 114: 3994-4001.
    CrossrefPubMedGoogle Scholar
  • 16 Drouet L, Paolucci F, Pasqualini N. et al. Plasma γA/γ’ fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?. Blood Coagul Fibrinolysis 1999; 10: S35-39.
    PubMedGoogle Scholar
  • 17 Cheung EY, Uitte de Willige S, Vos HL. et al. Fibrinogen γ’ in ischemic stroke: a case-control study. Stroke 2008; 39: 1033-1035.
    CrossrefPubMedGoogle Scholar
  • 18 Cheung EY, Vos HL, Kruip MJ. et al. Elevated fibrinogen γ’ ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome. Blood 2009; 114: 4603-4604 author reply 4604–4605.
    CrossrefPubMedGoogle Scholar
  • 19 Beck JD, Couper DJ, Falkner KL. et al. The Periodontitis and Vascular Events (PAVE) pilot study: adverse events. J Periodontol 2008; 79: 90-96.
    CrossrefPubMedGoogle Scholar
  • 20 Couper DJ, Beck JD, Falkner KL. et al. The Periodontitis and Vascular Events (PAVE) pilot study: recruitment, retention, and community care controls. J Periodontol 2008; 79: 80-89.
    CrossrefPubMedGoogle Scholar
  • 21 Offenbacher S, Beck JD, Moss K. et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 2009; 80: 190-201.
    CrossrefPubMedGoogle Scholar
  • 22 Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.
    CrossrefPubMedGoogle Scholar
  • 23 Beck JD, Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontol 2002; 7: 79-89.
    CrossrefPubMedGoogle Scholar
  • 24 Mosesson MW, Hernandez I, Raife TJ. et al. Plasma fibrinogen γ’ chain content in the thrombotic microangiopathy syndrome. J Thromb Haemost 2007; 5: 62-69.
    CrossrefPubMedGoogle Scholar
  • 25 Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ. et al. Genetic variation in the fibrinogen γ gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ’ levels. Blood 2005; 106: 4176-4183.
    CrossrefPubMedGoogle Scholar
  • 26 Uitte de Willige S, Rietveld IM, De Visser MC. et al. Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ‘/γA mRNA ratio. J Thromb Haemost 2007; 5: 1243-9.
    CrossrefPubMedGoogle Scholar
  • 27 de Willige SU, Pyle ME, Vos HL. et al. Fibrinogen γ gene 3’-end polymorphisms and risk of venous thromboembolism in the African-American and Caucasian population. Thromb Haemost 2009; 101: 1078-1084.
    Article in Thieme ConnectPubMedGoogle Scholar